Exchange Traded Concepts LLC Grows Position in Ventas, Inc. $VTR

Exchange Traded Concepts LLC raised its holdings in shares of Ventas, Inc. (NYSE:VTR) by 20.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 48,819 shares of the real estate investment trust’s stock after buying an additional 8,241 shares during the period. Exchange Traded Concepts LLC’s holdings in Ventas were worth $3,778,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in VTR. Vanguard Group Inc. grew its stake in Ventas by 2.5% in the 3rd quarter. Vanguard Group Inc. now owns 73,598,827 shares of the real estate investment trust’s stock worth $5,151,182,000 after acquiring an additional 1,802,515 shares in the last quarter. JPMorgan Chase & Co. increased its position in Ventas by 1.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 29,701,300 shares of the real estate investment trust’s stock valued at $2,078,794,000 after purchasing an additional 387,495 shares during the period. State Street Corp raised its holdings in shares of Ventas by 3.3% in the 3rd quarter. State Street Corp now owns 28,927,015 shares of the real estate investment trust’s stock valued at $2,038,176,000 after purchasing an additional 928,386 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Ventas by 2.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 6,601,143 shares of the real estate investment trust’s stock worth $462,002,000 after purchasing an additional 160,998 shares during the period. Finally, Northern Trust Corp boosted its stake in shares of Ventas by 1.7% during the third quarter. Northern Trust Corp now owns 6,402,941 shares of the real estate investment trust’s stock valued at $448,142,000 after purchasing an additional 108,990 shares in the last quarter. 94.18% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently commented on VTR. Morgan Stanley set a $90.00 price objective on shares of Ventas in a research note on Friday, February 13th. Wells Fargo & Company upped their price objective on Ventas from $88.00 to $93.00 and gave the stock an “overweight” rating in a research note on Thursday, March 26th. Mizuho raised their price objective on Ventas from $87.00 to $94.00 and gave the company an “outperform” rating in a research report on Wednesday, March 4th. Jefferies Financial Group reiterated a “buy” rating and issued a $93.00 target price on shares of Ventas in a report on Monday, December 15th. Finally, Citigroup raised their price target on shares of Ventas from $88.00 to $96.00 and gave the company a “buy” rating in a report on Wednesday, February 11th. Thirteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $90.47.

Ventas Stock Down 0.5%

Ventas stock opened at $81.52 on Tuesday. The business’s 50-day simple moving average is $83.11 and its two-hundred day simple moving average is $77.67. The company has a market cap of $38.72 billion, a PE ratio of 150.97, a PEG ratio of 2.02 and a beta of 0.73. Ventas, Inc. has a fifty-two week low of $60.15 and a fifty-two week high of $88.36. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67.

Ventas (NYSE:VTR) last issued its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.89 by ($0.74). The business had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. Ventas had a return on equity of 2.09% and a net margin of 4.31%.Ventas’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same quarter last year, the company posted $0.81 EPS. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be given a dividend of $0.52 per share. This is an increase from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a yield of 2.6%. The ex-dividend date is Tuesday, March 31st. Ventas’s dividend payout ratio (DPR) is 355.56%.

Insider Buying and Selling at Ventas

In other Ventas news, EVP Carey S. Roberts sold 35,532 shares of the business’s stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the transaction, the executive vice president directly owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. The trade was a 32.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Debra A. Cafaro sold 10,322 shares of the company’s stock in a transaction that occurred on Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the completion of the sale, the chief executive officer owned 1,114,034 shares in the company, valued at approximately $86,515,880.44. This represents a 0.92% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 86,106 shares of company stock valued at $6,931,397. 1.00% of the stock is owned by company insiders.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.